195 related articles for article (PubMed ID: 37400666)
1. Glioblastoma research on zebrafish xenograft models: a systematic review.
Pliakopanou A; Antonopoulos I; Darzenta N; Serifi I; Simos YV; Katsenos AP; Bellos S; Alexiou GA; Kyritsis AP; Leonardos I; Vezyraki P; Peschos D; Tsamis KI
Clin Transl Oncol; 2024 Feb; 26(2):311-325. PubMed ID: 37400666
[TBL] [Abstract][Full Text] [Related]
2. Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model.
Zeng A; Ye T; Cao D; Huang X; Yang Y; Chen X; Xie Y; Yao S; Zhao C
Sci Rep; 2017 Oct; 7(1):14372. PubMed ID: 29085081
[TBL] [Abstract][Full Text] [Related]
3. Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts.
Almstedt E; Rosén E; Gloger M; Stockgard R; Hekmati N; Koltowska K; Krona C; Nelander S
Neuro Oncol; 2022 May; 24(5):726-738. PubMed ID: 34919147
[TBL] [Abstract][Full Text] [Related]
4. Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish.
Ai X; Ye Z; Xiao C; Zhong J; Lancman JJ; Chen X; Pan X; Yang Y; Zhou L; Wang X; Shi H; Zhang D; Yao Y; Cao D; Zhao C
Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35199829
[TBL] [Abstract][Full Text] [Related]
5. An orthotopic glioblastoma animal model suitable for high-throughput screenings.
Pudelko L; Edwards S; Balan M; Nyqvist D; Al-Saadi J; Dittmer J; Almlöf I; Helleday T; Bräutigam L
Neuro Oncol; 2018 Oct; 20(11):1475-1484. PubMed ID: 29750281
[TBL] [Abstract][Full Text] [Related]
6. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.
Crommentuijn MH; Maguire CA; Niers JM; Vandertop WP; Badr CE; Würdinger T; Tannous BA
Mol Oncol; 2016 Apr; 10(4):625-34. PubMed ID: 26708508
[TBL] [Abstract][Full Text] [Related]
7. Quantification of glioblastoma progression in zebrafish xenografts: Adhesion to laminin alpha 5 promotes glioblastoma microtumor formation and inhibits cell invasion.
Gamble JT; Reed-Harris Y; Barton CL; La Du J; Tanguay R; Greenwood JA
Biochem Biophys Res Commun; 2018 Dec; 506(4):833-839. PubMed ID: 30389143
[TBL] [Abstract][Full Text] [Related]
8. Live Imaging of Microtubule Dynamics in Glioblastoma Cells Invading the Zebrafish Brain.
Peglion F; Coumailleau F; Etienne-Manneville S
J Vis Exp; 2022 Jul; (185):. PubMed ID: 35969108
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
10. Hallmarks of tumor-associated microglia response to experimental U87 human glioblastoma xenograft.
Dugandžija T; Drljača J; Bulajić D; Isaković A; Stilinović N; Sekulić S; Čapo I
Tissue Cell; 2021 Oct; 72():101557. PubMed ID: 34051646
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
[TBL] [Abstract][Full Text] [Related]
12. Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.
Lee J; Shin YJ; Lee K; Cho HJ; Sa JK; Lee SY; Kim SH; Lee J; Yoon Y; Nam DH
Cancer Res Treat; 2018 Jul; 50(3):1009-1022. PubMed ID: 29129044
[TBL] [Abstract][Full Text] [Related]
13. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.
Candolfi M; Curtin JF; Nichols WS; Muhammad AG; King GD; Pluhar GE; McNiel EA; Ohlfest JR; Freese AB; Moore PF; Lerner J; Lowenstein PR; Castro MG
J Neurooncol; 2007 Nov; 85(2):133-48. PubMed ID: 17874037
[TBL] [Abstract][Full Text] [Related]
14. Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease.
Radaelli E; Ceruti R; Patton V; Russo M; Degrassi A; Croci V; Caprera F; Stortini G; Scanziani E; Pesenti E; Alzani R
Histol Histopathol; 2009 Jul; 24(7):879-91. PubMed ID: 19475534
[TBL] [Abstract][Full Text] [Related]
15. Evaluating cancer cell line and patient-derived xenograft recapitulation of tumor and non-diseased tissue gene expression profiles in silico.
Williams AS; Wilk EJ; Fisher JL; Lasseigne BN
Cancer Rep (Hoboken); 2023 Sep; 6(9):e1874. PubMed ID: 37533331
[TBL] [Abstract][Full Text] [Related]
16. ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.
Cam M; Charan M; Welker AM; Dravid P; Studebaker AW; Leonard JR; Pierson CR; Nakano I; Beattie CE; Hwang EI; Kambhampati M; Nazarian J; Finlay JL; Cam H
Neuro Oncol; 2020 Mar; 22(3):345-356. PubMed ID: 31763674
[TBL] [Abstract][Full Text] [Related]
17. Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors.
Upton DH; Ziegler DS; Tsoli M
Methods Mol Biol; 2024; 2806():75-90. PubMed ID: 38676797
[TBL] [Abstract][Full Text] [Related]
18. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
[TBL] [Abstract][Full Text] [Related]
19. Orthotopic Patient-Derived Glioblastoma Xenografts in Mice.
Xu Z; Kader M; Sen R; Placantonakis DG
Methods Mol Biol; 2018; 1741():183-190. PubMed ID: 29392700
[TBL] [Abstract][Full Text] [Related]
20. Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.
Green AL; Ramkissoon SH; McCauley D; Jones K; Perry JA; Hsu JH; Ramkissoon LA; Maire CL; Hubbell-Engler B; Knoff DS; Shacham S; Ligon KL; Kung AL
Neuro Oncol; 2015 May; 17(5):697-707. PubMed ID: 25366336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
